Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)
Anirudh Veludhandi(Children's Healthcare of Atlanta), Lakshmanan Krishnamurti(Emory University), Monica Bhatia(Columbia University Irving Medical Center), Nitya Bakshi(Emory University), Allistair Abraham(Children's National), Peter A. Lane, Festus Olusola Olowoselu(University of Lagos), Matthew M. Hsieh(National Institutes of Health), Staci D. Arnold(Children's Healthcare of Atlanta), Sonali Chaudhury(Northwestern University), Gregory M.T. Guilcher(University of Calgary), Kirshma Khemani(Emory University), Tami John(Baylor College of Medicine), Lillian R. Meacham(Children's Healthcare of Atlanta), Kimberly A. Kasow(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k
Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
|Journal of Clinical Oncology|2009|418
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
|American Journal of Respiratory and Critical Care Medicine|2014|256
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248
Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society* Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2018|216